Crestline Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,469
Closed -$469K 709
2024
Q3
$469K Sell
4,469
-7,531
-63% -$881K 0.02% 379
2024
Q2
$1.71M Buy
+12,000
New +$1.38M 0.13% 137
2024
Q1
Sell
-53,828
Closed -$6.98M 158
2023
Q4
$6.98M Buy
53,828
+38,492
+251% +$5.31M 0.59% 59
2023
Q3
$2.5M Sell
15,336
-1,582
-9% -$278K 0.29% 94
2023
Q2
$3.1M Buy
+16,918
New +$2.44M 0.32% 89

Other funds holding ACLS

Crestline Management's ACLS Position: Q4 2024 in Review

Crestline Management sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 4,469 shares — an estimated $469K sold.

Crestline Management first reported a position in ACLS in Q2 2023 and held it in 5 quarters. The position peaked at $6.98M in Q4 2023. 324 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

  • Crestline Management reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
  • Crestline Management sold 4,469 Axcelis shares in Q4 2024, an estimated $469K.
  • Crestline Management first reported a position in Axcelis in Q2 2023 and held it in 5 quarters.
  • Crestline Management's Axcelis position peaked at $6.98M in Q4 2023.
  • 324 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on Crestline Management's 13F filing for Q4 2024, filed 14 Feb 2025.